Close
Nordic 9Nordic 9

Bruce Linton (investor - Angel Investor)

Canada brucelinton.com
See something wrong or missing? Let us know
Offices:Ottawa

Bruce Linton is known as former CEO at Canopy Growth Cooperation, the first cannabis producing company in North America to be listed on a major stock exchange

Average round investment:1.8M USD
Average number per year:2.0
Distribution: 2020 (2)
Portfolio companies: Denmark Octarine Bio
Mostly invests in: Denmark Denmark (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Bruce Linton

Name Criteria
France Oskare Capital
80%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Denmark Megatrend Invest a/s
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Denmark BioInnovation Institute
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Sweden Andreas Ehn
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Denmark Syddansk Innovation (SDTI)
78%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 3.5
  • Active last 12 months: Yes
Sweden Enexis AB
77%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Norway Sintef TTO
75%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Sweden KTH Holding
75%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Norway Inven2
75%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden Fredrik Wester
75%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Top